Compounds > octanoylcarnitine
Page last updated: 2024-09-03

octanoylcarnitine and Degenerative Diseases, Central Nervous System

octanoylcarnitine has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reiser, G; Schönfeld, P1

Other Studies

1 other study(ies) available for octanoylcarnitine and Degenerative Diseases, Central Nervous System

ArticleYear
Inhibition of β-oxidation is not a valid therapeutic tool for reducing oxidative stress in conditions of neurodegeneration.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:3

    Topics: Animals; Brain; Caprylates; Carnitine; Energy Metabolism; Homeostasis; Neurodegenerative Diseases; Oxidation-Reduction; Oxidative Stress; Rats

2017